SGX943 Approval Status
FDA Approved: No
Brand name: SGX943
Generic name: dusquetide
Company: Soligenix, Inc.
Treatment for: Melioidosis
SGX943 (dusquetide) is an Innate Defense Regulator (IDR) in development for the treatment of melioidosis.
Development Status and FDA Approval Process for SGX943
|May 31, 2016||FDA Grants Soligenix “Fast Track” Designation for SGX943 for the Treatment of Melioidosis|